Measurement of immunoglobulin G against mycobacterial antigen A60 in patients with cystic fibrosis and lung infection due to Mycobacterium abscessus

Clinical Infectious Diseases

Volumn 40, Issue 1, 2005, Pages 58-66

  Ferroni, Agnès ^a   Sermet Gaudelus, Isabelle ^a   Le Bourgeois, Muriel ^a   Pierre Audigier, Catherine ^a   Offredo, Catherine ^a   Rottmam, Martin ^d,e   Guillemot, Didier ^b   Bernède, Claire ^b   Vincent, Véronique ^c   Berche, Patrick ^a   Gaillard, Jean Louis ^d,e  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Ctr Rsrc Biostat Epidemiol/P   (France)

^c INSTITUT PASTEUR   (France)

^d RAYMOND POINCARÉ HOSPITAL   (France)

^e Laboratoire de Microbiologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

A60 ANTIGEN; IMMUNOGLOBULIN G; MYCOBACTERIUM ANTIGEN; UNCLASSIFIED DRUG;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM ABSCESSUS; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; SERODIAGNOSIS; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; CHILD; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; KINETICS; LUNG DISEASES; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; SENSITIVITY AND SPECIFICITY;

EID: 19944426455     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/426442     Document Type: Article

References (29)

1. Gilligan PH. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991;4:35-51.
2. Griffith DE. Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis. Am J Respir Crit Care Med 2003; 167:810-2.
3. Olivier KN, Weber DI, Wallace RJ Jr, et al. Nontuberculous mycobacteria. I. Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003; 167:828-34.
4. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria: an analysis of 154 patients. Am Rev Respir Dis 1993; 147:1271-8.
5. Sermet-Gaudelus I, Le Bourgeois M, Pierre-Audigier C, et al. Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis 2003;9:1587-91.
6. Tomashefski JF Jr, Stern RC, Demko CA, Doershuk CF. Nontuberculous mycobacteria in cystic fibrosis: an autopsy study. Am J Respir Crit Care Med 1996; 154:523-8.
7. Cullen AR, Cannon CL, Mark EJ, Colin AA. Mycobacterium abscessus infection in cystic fibrosis: colonization or infection? Am J Respir Crit Care Med 2000; 161:641-5.
8. Sanguinetti M, Ardito F, Fiscarelli E, et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol 2001; 39:816-9.
9. Brown-Elliott BA, Wallace RJ Jr. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002; 15:716-46.
10. American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Medical Section of the American Lung Association. Am J Respir Crit Care Med 1997; 156:51-25.
11. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356:1099-104.
12. Cocito CG. Properties of the mycobacterial antigen complex A60 and its applications to the diagnosis and prognosis of tuberculosis. Chest 1991; 100:1687-93.
13. Oliver A, Maiz L, Canton R, Escobar H, Baquero F, Gomez-Mampaso E. Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis 2001;32:1298-303.
14. Whittier S, Hopfer RL, Knowles MR, Gilligan PH. Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol 1993;31:861-4.
15. Whittier S, Olivier K, Gilligan P, Knowles M, Della-Latta P. Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. J Clin Microbiol 1997; 35:2706-8.
16. Nolte FS, Metchock B. Mycobacterium. In: Baron EJ, Murray PR, Pflaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:400-37.
17. Ringuet H, Akoua-Koffi C, Honore S, et al. hsp65 Sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol 1999; 37:852-7.
18. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978; 8:283-98.
19. Fauroux B, Delaisi B, Clement A, et al. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J 1997; 16:354-8.
20. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev 2003; 16:319-54.
21. Delacourt C, Gobin J, Gaillard JL, de Blic J, Véron M, Scheinmann P. Value of ELISA using antigen 60 for the diagnosis of tuberculosis in children. Chest 1993; 104:393-8.
22. Berger M. Inflammation in the lung in cystic fibrosis: a vicious cycle that does more harm than good? Clin Rev Allergy 1991;9:119-42.
23. Konstan MW, Berger M. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol 1997; 24:137-42; discussion, 159-61.
24. Charpin D, Herbault H, Gevaudan MJ, et al. Value of ELISA using A60 antigen in the diagnosis of active pulmonary tuberculosis. Am Rev Respir Dis 1990; 142:380-4.
25. Chiang IH, Suo J, Bai KJ, et al. Serodiagnosis of tuberculosis: a study comparing three specific mycobacterial antigens. Am J Respir Crit Care Med 1997; 156:906-11.
26. Alifano M, De Pascalis R, Sofia M, Faraone S, Del Pezzo M, Covelli I. Detection of IgG and IgA against the mycobacterial antigen A60 in patients with extrapulmonary tuberculosis. Thorax 1998; 53:377-80.
27. Kitada S, Maekura R, Toyoshima N, et al. Serodiagnosis of pulmonary disease due to Mycobacterium avium complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid antigens. Clin Infect Dis 2002;35:1328-35.
28. Olivier KN, Weber DJ, Lee JH, et al. Nontuberculous mycobacteria. II. Nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 2003; 167:835-40.
29. Torrens JK, Dawkins P, Conway SP, Moya E. Non-tuberculous mycobacteria in cystic fibrosis. Thorax 1998; 53:182-5.